Clinical Trial Update: A Real-World Observational Study: Zevorcabtagene Autoleucel Injection in Patients with Relapsed/Refractory Multiple Myeloma

View source ↗

Summary

This document reports a real-world observational study evaluating Zevorcabtagene Autoleucel for relapsed/refractory multiple myeloma, with the trial status NOT_…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Zevorcabtagene Autoleucel (zevorcabtagene autoleucel)

Snippet

Sponsor: CARsgen Therapeutics Co., Ltd. | Conditions: Relapsed/Refractory Multiple Myeloma | Status: NOT_YET_RECRUITING